-
The 2018
#PharmaRnDReview from#Pharmaprojects is now published, packed with facts, statistics and analysis to give you insight into the state of pharma R&D today, with a musical twist this year. Download your free copy at http://bit.ly/pharmapro18 -
GSK's mepolizumab
#asthma trials=1st anti-IL5 biologic filed for approval. Check out#Pharmaprojects top competitors pic.twitter.com/uxCxt09PC7
-
The 2018
#PharmaRnDReview#NASsupplement reporting on 2017's new drug launches and related trends is now available as a free download from#Pharmaprojects. Click here http://bit.ly/RD_2018_Supplement … to get your copy!pic.twitter.com/Rx3aMNPzi4
-
These days there is no abundance of spare time and money to easily handle
#pharmaprojects: you need be much more efficient than before. -
Congrats to my colleagues
@CitelineAlexW Tom Stirzaker & Igor Saposhnikov for their IBI Content Award for@Citeline#Pharmaprojects Trends! -
Who are your industry competitors - tweet
@Citeline_poppyG for a FREE#pharmaprojects demonstration#citeline -
tweet
@Citeline_poppyG - i will give you a free PERSONALIZED#PHARMAPROJECTS demonstration to analyze your competitive landscape!#citeline -
How did 2013 stack up for new active substance drug launches? Great summary by
@CitelineIanL#Pharmaprojects http://bit.ly/PxiyXf -
Who were Pharma's rock stars in 2017? Find out in Pharma Intelligence's latest Annual Pharma R&D review.
#Pharmaprojects http://bit.ly/pharmapro18 -
Discover
#Pharmaprojects, the powerful drug development intelligence you can rely on. Download the info flyer here http://bit.ly/2VT6jqy pic.twitter.com/SXHiPXGyw7
-
Click to read about how Novartis & J&J are backing technologies that could transform the human body into a disease-destroying machine. Data from
#pharmaprojects http://bit.ly/2Yh1EQt via@businessinsiderpic.twitter.com/GAv9WYyJqL
-
#biosimilars exploding.#Citeline shows the trend over past 5 yrs in#Pharmaprojects. Over 400 on the market. pic.twitter.com/A73YDGmb3l
-
The Pharma R&D Annual Review 2019 is based on the stats and data from
#Pharmaprojects & our whitepaper contains the whole 9 yards. Download your copy here today http://bit.ly/2VZ9Pja pic.twitter.com/qDyomWGqFY
-
Our essential whitepaper uses critical data from
#Pharmaprojects to examine the new entities that were successfully launched to market last year. Click to download your free copy here: http://bit.ly/2Gu4Ly8 pic.twitter.com/GJZNn2NluY
-
#Pharma confidence appears high after record year@CitelineIanL#Pharmaprojects analysis http://bit.ly/1HsjIK6 -
@Citeline's unique#pharmaprojects data set of trends in#drugdevelopment is analyzed in a new report at http://bit.ly/1v0pKem -
Remember the
#Ebola epidemic in West Africa? Infoma Group Citeline#PharmaProjects offers a review of Ebola R&D http://bit.ly/2xfJpOs -
The New Active Substances supplement to the 2017
#PharmaRnDReview from#Pharmaprojects is coming soon! Only 41 NASs were launched in 2016.
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.